AWM Investment Company, Inc. - Jun 10, 2021 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Role
10%+ Owner
Signature
Adam Stettner
Stock symbol
SCTL
Transactions as of
Jun 10, 2021
Transactions value $
-$1,029,891
Form type
4
Date filed
6/14/2021, 04:22 PM
Previous filing
May 21, 2021
Next filing
Sep 10, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Sale -$334K -150K -3.07% $2.23 4.74M Jun 10, 2021 By Limited Partnerships F1
transaction SCTL Common Stock Sale -$108K -50K -1.06% $2.16 4.69M Jun 11, 2021 By Limited Partnerships F1
transaction SCTL Common Stock Sale -$588K -267K -5.69% $2.20 4.42M Jun 11, 2021 By Limited Partnerships F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

AWM Investment Company, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This is a weighted average price.
F2 AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (QP), Special Situations Cayman Fund, L.P. (Cay), Special Situations Private Equity Fund, L.P. (PE) and Special Situations Life Sciences Fund, L.P. (LS). (LS and together with QP, Cay and PE the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 2,633,201 shares of Common Stock of the Issuer (the Shares) held by QP, 919,213 Shares held by Cay, 666,667 Shares held by PE and 200,000 Shares held by LS.
F3 Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM. The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.